Thursday, December 9

Advice on the third dose: authorities must act quickly

  • Sheraz Yaqub

    Chief Physician and Associate Professor, Oslo University Hospital / UiO

  • Mohammad Usman Frog

    Chief Physician, Østfold Hospital

  • John Torgils Vaage

    Professor and Chief Physician, UiO / Oslo University Hospital

  • Pål-Dag Line

    Chief Physician and Professor, Oslo University Hospital / UiO

  • Hakon haugaa

    Chief Medical Officer, Oslo University Hospital

The effect of the vaccine diminishes fairly quickly over time, the publication’s authors write.

Four strategies can reduce infection.

This is a discussion post. Opinions in the text are the responsibility of the writer.

Unfortunately, we are now seeing a new wave of covid-19 infections. The ascent curve is worryingly steep. In addition, the RS virus is wreaking havoc in young children, more of whom need hospital treatment than before. And not least, flu season is upon us.

This affects, among other things, the functioning of Norwegian hospitals in general and intensive care units in particular. An indirect effect of this is that planned operations should be postponed.

Many are well protected by the coronary vaccine, which allowed the community to open on September 25. However, the spread of infection from unvaccinated people, including unvaccinated healthcare professionals, is still reported. Most of those now hospitalized are fully vaccinated.

The effect diminishes

It turns out that the effect of the vaccine diminishes quite quickly over time. A recently published study shows that the protective effect of the second dose of the Moderna vaccine fell from 89% to 58% in six months. The efficacy of two doses of the Pfizer-Biontech vaccine also fell from 87 percent to 43 percent in the same period.

This may partly explain the increase in infection in several countries with high vaccine coverage, including Norway.

A recent article in The Lancet shows that if the infection first enters a home, it becomes one in four infected fully vaccinated. This may be due to the delta variant of the coronavirus and the fact that the effect of the vaccine diminishes over time.

Other studies have shown that a third dose of the vaccine provides good protection against minor and serious illnesses.

New research results

We have previously noted studies that show increased genetic vulnerability to severe covid disease among those with a genetic background from the Indian subcontinent (India, Pakistan, Bangladesh, Sri Lanka).

Now there are more research results like supports these findings. Therefore, the authorities should consider prioritizing this population group in order to save lives and health and no less important to reduce hospital admissions.

A third dose of vaccine provides good protection against minor and serious illnesses.

Therefore, to keep infection low, authorities and the National Institute of Public Health (NIPH) should soon consider the following strategies:

  1. Convince vaccine skeptics to get vaccinated to reduce hospitalizations and deaths. Emphasize that you are not only vaccinating yourself, you are also vaccinating to protect others.
  2. Offer the third dose of the vaccine to all people at risk (immunosuppressed, people with a serious underlying disease, people with an ethnic background from the Indian subcontinent), as well as socially critical occupational groups.
  3. Offer the third dose of the vaccine to anyone more than six months after the last dose of the vaccine.
  4. Increase the offers and information about the influenza vaccine so that as many people as possible, and especially those in the risk group for severe covid disease, also receive this vaccine.

With current knowledge about the rapidly decreasing effect of coronary vaccines and therefore the need for a third dose, at the same time we are aware of the risk groups for severe covid disease (underlying disease or genetic vulnerability), the health authorities must act quickly. . A vaccination strategy should be established to ensure that the health service is maintained and we do not also have indirect morbidity or mortality as a result of the pandemic.

Leave a Reply

Your email address will not be published. Required fields are marked *